Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Administration All age groups Haemophilus influenzae type B
Efficacy/effectiveness Safety Children (2-9 years) Adolescents (10-18 years) Meningococcal disease
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Administration Newborn (0-1 years) Adults (18+) Tuberculosis Typhoid Hepatitis B Diphtheria Tetanus Poliomyelitis Influenza Pertussis
Adolescents (10-18 years) Adults (18+) anthrax Agenda & Minutes United States of America Pneumococcal disease Japanese encephalitis Human papillomavirus (HPV) Rabies Influenza Meningococcal disease Pertussis Hepatitis A
Download:
Agenda & Minutes Argentina Poliomyelitis Measles Rubella Yellow fever Influenza Pneumococcal disease
Download:
Agenda & Minutes Argentina Dengue Pneumococcal disease Measles Rubella
Download:
anthrax supply shortage Agenda & Minutes United States of America Influenza Human papillomavirus (HPV) Mumps Herpes zoster Japanese encephalitis Pneumococcal disease
Download: